Overfeeding macronutrients to critically ill adults: Metabolic complications

Journal of the American Dietetic Association

Volumn 98, Issue 7, 1998, Pages 795-806

  Klein, Catherine J ^a   Stanek, Gena S ^a   Wiles III, Charles E ^a  

^a R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLINICAL ARTICLE; CLINICAL PRACTICE; CRITICAL ILLNESS; DEHYDRATION; DIETITIAN; FAT INTAKE; FATTY LIVER; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC DISORDER; NUTRITIONAL SUPPORT; OVERNUTRITION; PRACTICE GUIDELINE; PROTEIN INTAKE; REVIEW; UREMIA;

EID: 0031870736     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8223(98)00179-5     Document Type: Review

References (124)

1. Chwals WJ. Overfeeding the critically ill child: fact or fantasy? New Horizons. 1994;2:147-155.
2. Yamamoto T. Metabolic response to glucose overload in surgical stress: energy disposal in brown adipose tissue. Surg Today Jpn J Surg. 1996;26:151-157.
3. Askanazi J, Carpentier YA, Elwyn DH, Nordenstrom J, Jeevanandam M, Rosenbaum SH, Gump FE, Kinney JM. Influence of total parenteral nutrition oil fuel utilization in injury and sepsis. Ann Surg. 1980;191:40-46.
4. Reaich D, Maroni BJ. Protein and amino acid metabolism in renal disease and renal failure. In: Kopple JD, Massry SG, eds. Nutritional Management of Renal Disease. Baltimore, Md: Williams & Wilkins; 1997:1-33.
5. Beisel WR. Nutrition and infection. In: Linder MG, ed. Nutritional Biochemistry with Clinical Applications. 2nd ed. New York, NY: Elsevier Press; 1991:507-452.
6. Bessey PQ. Parenteral nutrition and trauma. In: Rombeau JL, Caldwell MD, eds. Clinical Nutrition: Patenteral Nutrition. 2nd ed. Philadelphia, Pa: WB Saunders; 1993:538-565.
7. Jeevanandam M. Trauma and sepsis. In: Cynober LA, ed. Amino Acid Metabolism and Therapy in Health, and Nutritional Disease. Boca Raton, Fia: CRC Press; 1995:245-255.
8. Mason JB, Russell RM. Parenteral nutrition in the elderly. In: Rombeau JL, Caldwell MD, eds. Clinical Nutrition: Parenteral Nutrition. 2nd ed. Philadelphia, Pa: WB Saunders; 1993:737-747.
9. Hansen LM, Hardie WR, Hidalgo J. Fat emulsion for intravenous administration: clinical experience with Intralipid 10%. Ann Surg. 1976;184:80-88.
10. Haber LM, Hawkins EP, Seilheimer DK, Saleem A. Fat overload syndrome: an autopsy study with evaluation of the coagulopathy. Am J Clin Pathol. 1988;89:223-227.
11. Campbell AN, Freedman MH, Pencharz PB, Zlotkin SH. Bleeding disorder from the "fat overload" syndrome. JPEN. 1984;8:447-449.
12. Heyman MB, Storch S, Ament ME. The fat overload syndrome. Am J Dis Child. 1981;135:628-630.
13. Roth B, Nilsson-Ehle P, Eliasson I. Possible role of short-term nutrition with fat emulsions for development of haemophagocytosis with multiple organ failure in a patient with traumatic brain injury. Intensive Care Med. 1993;19:111-114.
14. Freund U, Krausz Y, Levij IS, Eliakim M. Iatrogenic lipidosis following prolonged intravenous hyperalimentation. Am J Clin Nutr. 1975;28:1156-1160.
15. Taylor RF, Buckner CD. Fat overload from 10 percent soybean oil emulsion in a marrow transplant recipient. Wast J Med. 1982;136:345-349.
16. Belin RP, Bivins BA, Jona JZ, Young VL. Fat overload with a 10% soybean emulsion. Arch Surg. 1976;111:1391-1393.
17. Hessov I, Melson F, Haug A. Postmortem findings in three patients treated with intravenous fat emulsions. Arch Surg. 1979;114:66-68.
18. Meng HC, Kuyama T, Thompson SW, Ferrell JF. Toxicity testing of fat emulsions, I: tolerance study of long-term intravenous administration of intralipid in rats. Am J Clin Nutr. 1965;16:29-36.
19. Dahlstrom KA, Goulet OJ, Roberts RL, Ricour C, Ament ME. Lipid tolerance in children receiving long-term parenteral nutrition: a biochemical and immunologie study. J Pediatr. 1988;113:985-990.
20. Nussbaum MS, Li S, Bower RH, McFadden DW, Dayal R, Fischer JE. Addition of lipid to total parenteral nutrition prevents hepatic steatosis in rats by lowering the portal venous insulin/glucagon ratio. JPEN. 1992;16:106-109.
21. Li S, Nussbaum MS, Teague D, Gapen CL, Dayal R, Fischer JE. Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats. J Surg Res. 1988;4:639-648.
22. Kaminski DL, Adams A, Jellinek M. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery. 1980;88:93-100.
23. Kang KS, Galloway S, Ellis J, Solomon SS, Bean W, Reger JF, Cook GA, Olson G. Hepatic steatosis during convalescence from influenza B infection in ferrets with postprandial hyperinsulincamia. J Lab Clin Med. 1990;116:335-344.
24. Burke JF, Wolfe RR, Mullany CJ, Mathews DE, Bier DM. Glucose requirements following burn injury. Ann Surg. 1979;190:274-283.
25. Wolfe BM, Walker BK, Shaul DB, Wong L, Ruebner BH. Effect of total parenteral nutrition on hepatic histology. Arch Surg. 1988; 123:1084-1090.
26. Jebb SA, Prentice AM, Goldberg GR, Murgatroyd PR, Black AE, Coward WA. Changes in macronutrient balance during over- and underfeeding assessed by 12-d continuous whole-body calorimetry. Am J Clin Nutr. 1996;64:259-266.
27. Hellerstcin MK, Schwarz J, Neese RA. Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr. 1996;16:523-557.
28. Aarsland A, Chinkes D, Wolfe RR. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulincmia in normal man. J Clin Invest. 1996;98:2008-2017.
29. Hall RI, Grant JP, Ross LH, Coleman RA, Bozovic MG, Quarfordt SH. Pathogenesis of hepatic steatosis in the parenterally fed rat. J Clin Invest. 1984;74:1658-1668.
30. Yeh SL, Chen WJ, Huang PC. Effects of L-glutamine on induced hepatosteatosis in rats receiving total parenteral nutrition. J Formos Med Assoc. 1995;94:593-599.
31. Ney DM, Yang H, Smith SM, Unterman TG. High-calorie total parenteral nutrition reduces hepatic insulin-like growth factor-I mRN A and alters serum levels of insulin-like growth factor-binding Protein-1, -3, -5, and -6 in the rat. Metabolism. 1995;44:152-160.
32. Keim NL, Mares-Perlman JA. Development of hepatic steatosis and essential fatty acid deficiency in rats with hypercaloric, fat-free parenteral nutrition. J Nutr. 1984;114:1807-1815.
33. Zamir O, Nussbaum MS, Bhadra S, Subbiah MT, Rafferty JF, Fischer JE. Effect of enteral feeding on hepatic steatosis induced by total parenteral nutrition. JPEN. 1994;18:20-25.
34. Mock DM, Johnson SB, Holman RT. Effects of biotin deficiency on serum fatty acid composition: evidence for abnormalities in humans. J Nutr. 1988;118:342-348.
35. Whalen GF, Shamberger RC, Perez-Atayde A, Folkman J. A proposed cause for the hepatic dysfunction associated with parenteral nutrition. J Pediatr Surg. 1990;25:622-626.
36. Shronts EP. Essential nature of choline with implications for total parenteral nutrition. J Am Diet Assoc. 1997;97:639-646,649.
37. Food and Nutrition Board. Recommended Dietary Allowances. 10th ed. Washington, DC: National Academy Press; 1989.
38. Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Gornbein J, Ament ME. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology. 1995;22:1399-1403.
39. Narkewiez MR, Caldwell S, Jones G. Cysteine supplementation and reduction of total parenleral nutrition-induced hepatic lipid accumulation in the weanling rat. J Pediatr Gastroenterol Nutr. 1995;21:18-24.
40. Tuma DJ, Sorrell MF, Barak AJ. Phenobarbital induced fatty livers in the rat. Gastroenterology. 1973;64:199. Abstract.
41. Adolph M, Hailer S, Echart J. Serum phospholipid fatty acids in severely injured patients on total parenteral nutrition with medium chain/long chain triglyceride emulsions. Ann Nutr Metab. 1995;39:251-260.
42. Richardson TJ, Sgoutas D. Essential fatty acid deficiency in four adult patients during total parenteral nutrition. Am J Clin Nutr. 1975; 28:258-263.
43. Williams MA, Timoco J, Hincebergs I, Thomas B. Increased plasma triglyceride secretion in EFA-deficient rats fed diets with or without saturated fat. Lipids. 1989;24:448-453.
44. Jeevanandam M, Grote-Holman AE, Chikenji T, Askanazi J, Elwyn DH, Kinney JM. Effects of glucose on fuel utilization and glycerol turnover in normal and injured man. Crit Care Med. 1990; 18:125-134.
45. Wolfe RR, Wolfe MH, Shulman G. Glucose metabolism in humans. In: Turnland JR, Johnson PE, eds. Stable Isotopes in Nutrition. Washington, DC: American Chemical Society; 1984:175-189.
46. Wolfe RR, O'Donnell TF Jr, Stone MD, Richmand DA, Burke JF. Investigation of factors determining the optimal glucose infusion rate in total parenteral nutrition. Metabolism. 1980;29:892-900.
47. Askanazi J, Rosenbaum SH, Hyman AI, Silverberg PA, Milic-Emili J, Kinney JM. Respiratory changes induced by the large glucose loads of total parenteral nutrition. JAMA. 1980;243:1444-1447.
48. Rodriguez JL, Askanazi J, Weissman C, Hensle TW, Rosenbaum SH, Kinney JM. Ventilatory and metabolic effects of glucose infusions. Chest. 1985;88:512-518.
49. Covelli HD, Black JW, Olsen MS, Beekman JF. Respiratory failure precipitated by high carbohydrate loads. Ann Intern Med. 1981;95:579-581.
50. Aranda-Michel J, Morgan SL. Overfeeding in a patient with kwashiorkor syndrome. Nutrition. 1996;12:623-625.
51. Dark DS, Pingleton SK, Kerby GR. Hypercapnia during weaning: a complication of nutritional support. Chest. 1985;88:141-143.
52. Valente JF, Anderson GL, Branson RD, Johnson DJ, Davis K Jr, Porembka DT. Disadvantages of prolonged sedation in the critical care unit. Crit Care Med. 1994;22:710-712.
53. Horton TJ, Drougas H, Brachey A, Reed GW, Peters JC, Hill JO. Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am J Clin Nutr. 1995;62:19-29.
54. Casper K, Matthews DE, Heymsfield SB. Overfeeding: cardiovascular and metabolic response during continuous formula infusion in adult humans. Am J Clin Nutr. 1990;52:602-609.
55. Roberts SB, Fuss P, Dallal GE, Atkinson A, Evans WJ, Joseph L, Fiatarone MA, Greenberg AS, Young VR. Effects of age on energy expenditure and substrate oxidation during experimental overfeeding in healthy men. J Gerontol A Biol Sci Med Sci. 1996;51(2):B148-B157.
56. Wolfe RR, Allsop JR, Burke JF. Glucose metabolism in man: responses to intravenous glucose infusion. Metabolism. 1979;28:210-220.
57. Wolfe RR. Herman Award lecture, 1996: relation of metabolic studies to clinical nutrition: the example of burn injury. Am J Clin Nutr. 1996;64:800-808.
58. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuons infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract. 1996;11:151-156.
59. Dunham CM, Dainiano AM, Wiles CE, Cushing BM. Post-traumatic multiple organ dysfunction syndrome: infection is an uncommon antecedent risk factor. Injury. 1995;26:373-378.
60. Wallace LK, Starr NJ, Leventhal MJ, Estafanous FG. Hyperglycemia on ICU admission after CABG is associated with increased risk of mediastinitis or wound infection. Anesthesiology. 1996;85:A286. Abstract.
61. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-361.
62. Verhofstad MHJ, Hendriks T. Complete prevention of impaired anastomotic healing in diabetic rats requires preoperative blood glucose control. Br J Surg. 1996;83:1717-1721.
63. Brenner WI, Lansky Z, Engelman RM, Stahl WM. Hyperosmolar coma in surgical patients: an iatrogenic disease of increasing incidence. Ann Surg. 1973;178:651-654.
64. Levine SN, Sanson TH. Treatment of hyperglycemic hyperosmolar nonketotic syndrome. Drugs. 1989;38:462-472.
65. Lubran MM. Renal function in the elderly. Ann Clin Lab Sci. 1995;25:122-133.
66. Walike JW. Tube feeding syndrome in head and neck surgery. Arch Otolaryngol Head Neck Surg. 1969;89:117-120.
67. Gault MH, Dixon ME, Doyle M, Cohen WM. Hypernatremia, azotemia, and dehydration due to high-protein tube feeding. Ann Intern Med. 1968:68:778-791.
68. Acheson KJ, Schultz Y, Bessard T, Anantharaman K, Flatt J, Jequier E. Glycogen storage capacity and de novo lipogenesis during massive carbohydrate overfeeding in man. Am J Clin Nutr. 1988; 48:240-247.
69. Jatho GJ, Schneeman BO, Davis PA, Kasmin-Karakas S. The effect of high-carbohydrate intake on substrate utilization in postmenopausal women. J Am Diet Assoc. 1996;96(suppl):A-11. Abstract.
70. Kinney JM. Clinical biochemistry: implications for nutritional support. JPEN. 1990;14(suppl):148S-156S.
71. Eddleston JM, Shelly MP. The effect on serum lipid concentrations of a prolonged infusion of propofol-hypertriglyceridemia associated with propofoladministration. Intensive Care Med. 1991;17:424-426.
72. Lowry TS, Dunlap AW, Brown RO, Dickerson KN, Kudsk KA. Pharmacologic influence on nutrition support therapy: use of propofol in a patient receiving combined enterai and parenteral nutrition support. Nutr Clin Pract. 1996;11:147-149.
73. Pearson K, Kruse G, Demetrion E. Effects of propofol sedation on common laboratory measurements. Anesthesiology. 1990;73:A298. Abstract.
74. Barr J. Propofol: anew drug for sedation in the intensive care unit. Int Anesthesiol Clin. 1995;33:131-154.
75. Fraley DS, Adler S, Bruns F, Segal D. Metabolic acidosis after hyperalimentation with casein hydrolysate. Ann Intern Med. 1978; 88:352-354.
76. Heird WC, Dell RB, Driscoll JM, Grebin B, Winters RW. Metabolic acidosis resulting from intravenous alimentation mixtures containing synthetic amino acids. N Engl J Med. 1972;287:943-948.
77. Bauer B, Gardner L, Holdy K, Kalafer M. Case report: metabolic acidosis associated with high protein enterai nutrition (EN). Presented at: Nutrition and Metabolic Support: Challenges in the Age of Managed Care; 21st Clinical Congress of the American Society for Parenteral and Enteral Nutrition; January 26-29, 1997; San Francisco, Calif.
78. Welbourne TC, Mu X. Amino acid metabolism in acidosis. In: Cynober LA, ed. Amino Acid Metabolism and Therapy in Health and Nutritional Disease. Boca Raton, Fla: CRC Press; 1995;299-308.
79. Brooks MJ, Melnik G. The refeeding syndrome: an approach to understanding its complications and preventing its occurrence. Pharmacotherapy. 1995;15:713-726.
80. Berne RM, Levy MN. Physiology. 2nd ed. Washington, DC: CV Mosby; 1988:864.
81. Heymsfield SB, Bethel RA, Ansley JD, Gibbs DM, Feiner JM, Nutter DO. Cardiac abnormalities in cachectie patients before and during nutritional repletion. Am Heart J. 1978;95:584-594.
82. Solomon SM, Kirby DF. The refeeding syndrome: a review. JPEN. 1990;14:90-97.
83. Cravo ML, Gloria LM, Selhub J, Nadeau MR, Camilo ME, Resende MP, Cardoso JN, Leitao CN, Mira FCJ. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr. 1996;63:220-224.
84. Halsted C. Alcohol: medical and nutritional effects. In: Ziegler EE, Filer LJ Jr, eds. Present. Knowledge in Nutrition. 7th ed. Washington, DC: ILSI Press; 1997:547-556.
85. Weinsier RL, Krumdieck CL. Death resulting from overzealous total parenteral nutrition: the refeeding syndrome revisited. Am J Clin Nutr. 1980;34:393-399.
86. Boyle WA, Shear JM, White PF, Schuller D. Tolerance and hyperlipemia during long-term sedation with propofol. Anesthesiology. 1990;73:A244. Abstract.
87. Baker SP, O'Neill B, Haddon W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187-196.
88. Ellcrbusch M, Koszyk P. Outcome in critically ill obese patients on total parenteral nutrition (TPN). Am J Clin Nutr. 1997;66:222. Abstract.
89. Harris JA, Benedict, FG. A Biometric Study of Basal Metabolism in Man. Washington, DC: Carnegie Institution of Washington; 1919.
90. Ireton-Jones CS, Turner WW Jr. Actual or ideal body weight: which should be used to predict energy expenditure? J Am Diet Assoc. 1991;91:193-195.
91. Amato P, Keating KP, Quercia RA, Karbonic J. Formulaic methods of estimating calorie requirements in mechanically ventilated obese patients: a reappraisal. Nutr Clin Pract. 1995;10:229-232.
92. Silverman DW. Assessment and nutrition management of the patient with multiple organ dysfunction syndrome. In: Winkler MF, Lysen LK, eds. Suggested Guidelines for Nutrition arid Metabolic Management of Adult Patients Receiving Nutrition Support. 2nd ed. Chicago, Ill: American Dietetic Association; 1993:99-111.
93. American Society for Parenteral and Enteral Nutrition Board of Directors. Guidelines for the use of parenteral and enterai nutrition in adult and pediatric patients. JPEN. 1993;17(suppl):1SA-52SA.
94. Weissman C, Kemper M, Hyman AI. Variation in the resting metabolic rate of mechanically ventilated critically ill patients. Anesth Analg. 1989;68:457-461.
95. Smyrnios NA, Curley FJ, Shaker KG. Accuracy of 30-minute indirect calorimetry studies in predicting 24-hour energy expenditure in mechanically ventilated, critically ill patients. JPEN. 1997;21:168-174.
96. Zaloga GP, Roberts P. Permissive underfeeding. New Horiz. 1994;2:257-263.
97. Taveroff A, McArdle AH, Rybka WB. Reducing parenteral energy and protein intake improves metabolic homeostasis after bone marrow transplantation. Am J Clin Nutr. 1991;54:1087-1092.
98. Alexander JW, Gonce SJ, Miskell PW, Peck MD, Sax H. A new model for studying nutrition in peritonitis: the adverse effect of overfeeding. Ann Surg. 1989;209:334-340.
99. Miles JM. Yes, protein should be included. Nutr Clin Pract. 1996; 11:204-205.
100. Askanazi J, Elwyn DH, Silverberg PA, Rosenbaum SH, Kinney JM. Respiratory distress secondary to a high carbohydrate load: a case report. Surgery. 1980;87:596-598.
101. Frankel WL, Evans NJ, Rombeau JL. Scientific rationale and clinical application of parenteral nutrition in critically ill patients. In: Rombeau JL, Caldwell MD, eds. Clinical Nutrition: Parenteral Nutrition. 2nd ed. Philadelphia, Pa: WB Saunders; 1993;597-616.
102. Bell SJ. Assessment, and nutrition management of the patient with diabetes. In: Winkler MF, Lysen LK, eds. Suggested Guidelines for Nutrition and Metabolic Management of Adult Patients Receiving Nutrition Support. 2nd ed. Chicago, Ill: American Dietetic Association; 1993:91-98.
103. Macfie J, Courtney DF, Brennan TG. Continuous versus intermittent infusion of fat emulsions during total parenteral nutrition: clinical trial. Nutrition. 1991;7:99-103.
104. Peck MD, Alexander JW, Gonce SJ, Miskell PW. Low protein diets improve survival from peritonitis is guinea pigs. Ann Surg. 1989;209:448-454.
105. Greig PD, Elwyn DH, Askanazi J, Kinney JM. Parenteral nutrition in septic patients: effect of increasing nitrogen intake. Am J Clin Nutr. 1987;39:41-44.
106. Bessey PQ. Nutritional support of the critically ill: how much nitrogen? Surg Forum. 1988;39:41-44.
107. Wolfe RR, Goodenough RD, Burke JF, Wolfe MH. Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann Surg. 1983;197:163-171.
108. Shaw JHF, Wildborne M, Wolfe RR. Whole body protein kinetics in severely septic patients. Ann Surg. 1987;205:288-294.
109. Larsson J, Lennmarken C, Martensson J, Sandstedt S, Vinnars K. Nitrogen requirements in severely injured patients. Br J Surg. 1990; 77:413-416.
110. Iapichino G, Radrizzani D, Solca M, Pesenti A, Gattmoni L, Ferro A, Leoni L, Langer M, Vesconi S, Damia G. The main determinants of nitrogen balance during total parenteral nutrition in critically ill injured patients. Intensive Care Med. 1984;10:251-254.
111. Clevenger FW, Rodriguez DJ, Demarest GB, Osier TM, Olson SE, Fry DE. Protein and energy tolerance by stressed geriatric patients. J Surg Res. 1992;52:135-139.
112. Winkler MF, Lysen LK. Assessment and nutrition management of the patient receiving parenteral nutrition support. In: Winkler MF, Lysen LK, eds. Suggested Guidelines for Nutrition and Metabolic Management of Adult Patients Receiving Nutrition Support. 2nd ed. Chicago, Ill: American Dietetic Association; 1993:20-29.
113. Sacks GS. Is IV lipid emulsion safe in patients with hypertriglyceridemia. Nutr Clin Pract. 1997;12:129-123.
114. Innis SM. Essential dietary lipids. In: Ziegler EE, Filer LJ Jr, eds. Present Knowledge in Nutrition. 7th ed. Washington, DC: ILSI Press; 1997;58-66.
115. Flatt JP. The biochemistry of energy expenditure. In: Bray GA, ed. Recent Advances in Obesity Research. vol 2. London, England: Newman; 1978:211-228.
116. James BC. What does monitoring adverse drug events tell us about quality? Presented at: Measuring the Quality of Health Care-State of the Art; National Roundtable on Health Care Quality sponsored by the Insitute of Medicine; September 12-13, 1996;Washington, DC.
117. Matarese LE. Assessment and nutrition management of the patient with renal disease. In: Winkler MF, Lysen LK, eds. Suggested Guidelines for Nutrition and Metabolic Management of Adult Patients Receiving Nutrition Support. 2nd ed. Chicago, Ill: American Dietetic Association; 1993:112-124.
118. Sax HC, Talamini MA, Brackett K, Fischer JE. Hepatic stcatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal scrum hepatic enzyme levels. Surgery. 1986;100:697-704.
119. Herrenbruck T, Beyer P. Factors related to the occurrence of hyperglycemia in patients receiving total parenteral nutrition. J Am Diet Assoc. 1996;96(suppl):A-11. Abstract.
120. Meguid MM, Akahoshi MP, Jeffers S, Hayashi RJ, Hammond WG. Amelioration of metabolic complications of conventional total parenteral nutrition. Arch Surg. 1984;119:1294-1298.
121. Marik PE, Bedigian MK. Refeeding hypophosphalemia in critically ill patients in an intensive care unit: a prospective study. Arch Surg. 1996;131:1043-1047.
122. Rosen GH, Boullata JI, O'Rangers EA, Enow NB, Shin B. Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia. Crit Cure Med. 1995;23:1204-1210.
123. Hamill RJ, Robinson LM, Wexler HR, Moote C. Efficacy and safety of potassium infusion therapy in hypokalemic critically ill patients. Crit Care Med. 1991;19:694-699.
124. Olcrich MA, Rude RK. Should we supplement magnesium in critically ill patients? New Horiz. 1994;2:186-192.